Age-adjusted comorbidity score stratifies mortality in prostate CA

June 25, 2015
Age-adjusted comorbidity score stratifies mortality in prostate CA

(HealthDay)—An age-adjusted prostate cancer-specific comorbidity index (PCCI) can stratify the risk of long-term nonprostate cancer-related mortality, according to a study published in the July issue of The Journal of Urology.

Timothy J. Daskivich, M.D., from the David Geffen School of Medicine at the University of California-Los Angeles, and colleagues sampled 1,598 men diagnosed with between 1998 and 2004. The authors determined the risk of nonprostate cancer-related mortality associated with age at diagnosis and PCCI score in testing and validation cohorts. Risk was converted into a 10-point scoring system.

The researchers found that in the testing and validation cohorts, PCCI score and age correlated with similar hazards of other-cause mortality. Equivalent risks were seen for each six-year increase in age at diagnosis of greater than 60 years and for one additional PCCI point. The age-adjusted PCCI scores were strongly predictive of other-cause mortality. For a score of 0, 1 to 2, 3 to 4, 5 to 6, 7 to 9, and 10+, the subhazard ratios of other-cause mortality versus 0 were 2.0, 4.0, 8.7, 14.7, and 43.2, respectively; 10-year cumulative incidence of other-cause mortality was 10, 19, 35, 60, 79, and 99 percent, respectively.

"The -adjusted PCCI strongly stratifies the risk of long-term, other-cause ," the authors write. "It may be incorporated into shared decision-making to decrease overtreatment of older and chronically ill men with cancer."

One author disclosed a financial tie to WiserCare.

Explore further: Benefit of aggressive prostate CA Tx weakens as comorbidity rises

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Age, creatinine, ejection fraction predict post-MI survival

April 20, 2015

(HealthDay)—A simple age, creatinine, and ejection fraction (ACEF) score can predict one-year mortality risk in myocardial infarction 30-day survivors who underwent percutaneous coronary intervention, according to a study ...

Risk score IDs one-year mortality in elderly with NSTE-ACS

June 19, 2015

(HealthDay)—A risk score involving five covariates can predict one-year mortality risk in patients ≥75 years presenting with non-ST-segment elevation (NSTE) acute coronary syndromes (ACS), according to a study published ...

Age-related macular degeneration, mortality linked

May 12, 2015

(HealthDay)—Age-related macular degeneration (AMD) is a predictor of poor survival, especially among women aged 80 years and older, according to a study published online May 4 in the Journal of the American Geriatrics Society.

Recommended for you

Targeted drug shows promise in rare advanced kidney cancer

June 23, 2017

Some patients with a form of advanced kidney cancer that carries a poor prognosis benefited from an experimental drug targeted to an abnormal genetic pathway causing cancerous growth, according to research led by a Dana-Farber ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.